title: How to avoid pitfalls in antibody use.
abstract: Antibody use is ubiquitous in the biomedical sciences. However, determining best research practices has not been trivial. Many commercially available antibodies and antibody-conjugates are poorly characterized and lack proper validation. Uncritical application of such useless tools has contributed to the reproducibility crisis in biomedical research. Despite early initiatives such as MIAPAR or PSI-PAR, a best practice guideline for antibody characterization is still not in prospect. Here, we analyze 24 antibody-related databases and compare their content with regard to validation aspects and coverage. We also provide a flowchart for end-users with all necessary steps to facilitate finding and choosing specific and sensitive antibodies for their experiments. Based on a growing demand for better and standardized validation procedures and characterization guidelines for antibody molecules we have summarized our findings in a five-point plan. We intend to keep the discussion alive and hope that properly used antibodies will remain as central to biomedicine as they are today.
authors.affiliation: Department of Ophthalmology, University Hospital Regensburg, Regensburg, 93053, Germany.
authors.forename: Diana
authors.initials: D
authors.lastname: Pauly
authors.affiliation: Department of Immunotechnology, University of Potsdam, Potsdam, 14476, Germany.
authors.forename: Katja
authors.initials: K
authors.lastname: Hanack
keywords: antibodies; application; characterization; databases; target; unique identifier; validation
references.citation: Analyst. 2009 Oct;134(10):2028-39
references.pmid: 19768210
references.citation: Mol Cell Proteomics. 2010 Jan;9(1):1-10
references.pmid: 19674966
references.citation: Mol Cell Proteomics. 2008 Oct;7(10):2028-37
references.pmid: 18667413
references.citation: Biotechniques. 2010 Mar;48(3):197-209
references.pmid: 20359301
references.citation: PeerJ. 2013 Sep 05;1:e148
references.pmid: 24032093
references.citation: Genome Res. 2012 Sep;22(9):1813-31
references.pmid: 22955991
references.citation: Nat Struct Mol Biol. 2011 Jan;18(1):91-3
references.pmid: 21131980
references.citation: PLoS One. 2014 May 05;9(5):e96371
references.pmid: 24797388
references.citation: BMC Bioinformatics. 2006 Apr 06;7:192
references.pmid: 16600027
references.citation: Nat Biotechnol. 2010 Jul;28(7):650-3
references.pmid: 20622827
references.citation: Nature. 2015 May 21;521(7552):274-6
references.pmid: 25993940
references.citation: F1000Res. 2015 May 29;4:134
references.pmid: 26594330
references.citation: J Vis Exp. 2011 May 01;(51):
references.pmid: 21559009
references.citation: J Immunol Methods. 2013 Jan 31;387(1-2):167-72
references.pmid: 23098839
references.citation: F1000Res. 2014 Nov 05;3:266
references.pmid: 25580232
references.citation: Immunol Lett. 2013 Mar;151(1-2):39-43
references.pmid: 23453960
references.citation: J Biotechnol. 2011 Dec 10;156(3):173-81
references.pmid: 21968261
references.citation: Nature. 2015 Feb 5;518(7537):27-9
references.pmid: 25652980